bendunn

BioBullets: The Great Dispersion

Mike and Ben talk about Scott Galloway's theory of the Great Dispersion – the impact of COVID on business models like direct-to-consumer and how far they're spreading

Introduction to Horizon 3

A chance to meet with Mike, Horizon 3's Executive Chairman, and Matt, the Chief Investment Officer, as they talk about Horizon 3's origins, who its right for and what makes the fund distinctive.

Topical investment strategies in biotech

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara. In this episode Matt will be joined by Horizon 3 Biotech Life Sciences and Capital Markets Executive Dr Graeme Wald and Investment Analyst Scott Power who will be sharing topical investment strategies.

Horizon 3 Biotech Fund and what drives investment decisions

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara. Matt & Scott Power, Investment Committee at Horizon 3 Biotech, discuss the origins of the Horizon 3 fund, what drives investment decisions and some of Scott's recommendations for investment in the coming months

Matt talks to Dimerix & Crucible Investments

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara. Matt & Scott Power speak to Dr Nina Webster from Dimerix and CEO & MD Dr Matthijs Smith of Crucible Investments.

Healthcare investment and the outlook for 2021

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara. In this episode Matt will be joined by Investment Analyst Scott Power at Morgans to discuss healthcare investment and the outlook for 2021. Malcolm McColl, CEO & Co-Founder of ImmVirX will also join the panel to discuss his experience at Viralytics and what he is […]

Contact

Email your message to H3 Healthcare